# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.09) per share. This is a 10 percent increase over losses of $(0.10) pe...
Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced medical products, is proud to announce a major enhancement to its ...